Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

ClinicalTrials.gov ID: NCT06323928

Public ClinicalTrials.gov record NCT06323928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Trial of Lu AG09222 for the Prevention of Migraine in Participants With Unsuccessful Prior Preventive Treatments

Study identification

NCT ID
NCT06323928
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
874 participants

Conditions and interventions

Conditions

Interventions

  • Lu AG09222 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2024
Primary completion
Jan 15, 2026
Completion
Mar 15, 2026
Last update posted
Jun 11, 2026

2024 – 2026

United States locations

U.S. sites
28
U.S. states
12
U.S. cities
27
Facility City State ZIP Site status
Accel Research Sites Network - Neurology and Neurodiagnostic of Alabama Hoover Alabama 35244-5700
Profound Research - Neurology Center of Southern California Carlsbad California 92011
Neurology Center of North Orange County Fullerton California 92835
CenExel CNS Los Alamitos California 90720
ASCLEPES Research Centers Sherman Oaks California 91403
Ki Health Partners LLC DBA New England Institute for Clinical Research Stamford Connecticut 06905
K2 Medical Research - Winter Garden Clermont Florida 34711
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256
K2 Medical Research, LLC - Maitland Maitland Florida 32751
Aqualane Clinical Research Naples Florida 34105
K2 Medical Research Tampa LLC Tampa Florida 33607
Premiere Research Institute Palm Beach West Palm Beach Florida 33407
Accellacare and McFarland Clinic Ames Iowa 50010
Clinical Research Professionals Chesterfield Missouri 63005
Healthcare Research Network Hazelwood Missouri 63042
Dent Neurosciences Research Center, Inc. Amherst New York 14226
North Suffolk Neurology, PC. Port Jefferson Station New York 11776
Accellacare of Cary - Cary Medical Group Cary North Carolina 27518
Headache Wellness Center Greensboro North Carolina 27405
Raleigh Medical Group Raleigh North Carolina 27609
M3 Wake Research, Inc Raleigh North Carolina 27612
Accellacare of Rocky Mount Rocky Mount North Carolina 27804
Triad Neurological Associates Winston-Salem North Carolina 27103
Accellacare of Charleston Mt. Pleasant South Carolina 29464
Internal Medicine and Pediatric Associates of Bristol, PC Bristol Tennessee 37620
Cedar Health Research, LLC Dallas Texas 75251
Mercury Clinical Research Sugar Land Texas 77478
MedStar Health - Neurology Clinic at McLean McLean Virginia 22101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06323928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06323928 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →